Načítá se...
Peptide-Targeted Polyglutamic Acid Doxorubicin Conjugates for the Treatment of α(v)β(6)-Positive Cancers
Most chemotherapeutics exert their effects on tumor cells as well as their healthy counterparts, resulting in dose limiting side effects. Cell-specific delivery of therapeutics can increase the therapeutic window for treatment by maintaining the therapeutic efficacy while decreasing the untoward sid...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4053474/ https://ncbi.nlm.nih.gov/pubmed/18710273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bc800154f |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|